For a medication class with documented neuropsychiatric monitoring guidance, this placement is hard to defend
, Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial, Lancet Diabetes Endocrinol
Referral to gastroenterology is appropriate when patients experience persistent symptoms despite conservative management, require objective gastroparesis diagnosis, or need specialized nutritional support
Each 32mg pen ships with a batch-matched certificate of analysis covering peptide identity, HPLC purity, and sterility parameters
Information on active UK trials can be found via the following resources: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) a UK-specific portal for finding clinical trials ISRCTN registry (isrctn.com) ClinicalTrials.gov (clinicaltrials.gov) Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial
Appetite suppression becomes stronger
